Related Experiment Video
Updated: Mar 19, 2026

In Silico Clinical Trials for Cardiovascular Disease
Published on: May 27, 2022
Precision cardiovascular medicine with big data and AI.
Qian Xu1, Yiwen Li2, MengMeng Zhu1
1National Clinical Research Center for TCM Cardiology, Xiyuan Hospital of China Academy of Chinese Medical Sciences, Beijing, China.
Artificial intelligence (AI) and big data are revolutionizing cardiovascular medicine by integrating diverse health information. However, challenges remain in translating these advancements into widespread clinical benefits for cardiovascular disease patients.
Area of Science:
- Cardiovascular Medicine
- Medical Informatics
- Artificial Intelligence
Background:
- Cardiovascular disease is a major global health burden.
- Emerging technologies offer new approaches to cardiovascular care.
Purpose of the Study:
- To explore how big data and AI are transforming precision cardiovascular medicine.
- To identify the potential benefits and current limitations of AI in cardiovascular care.
Main Methods:
- Multimodal data integration from electronic health records (EHRs), imaging, omics, and wearables.
- Application of AI algorithms across the patient care continuum.
- Analysis of predictive, diagnostic, and therapeutic optimization strategies.
Main Results:
- AI enables comprehensive data integration for enhanced cardiovascular insights.
- Potential for predictive, diagnostic, and therapeutic optimization is demonstrated.
- Clinical translation is hindered by data gaps and implementation hurdles.
Conclusions:
- AI and big data integration hold significant promise for precision cardiovascular medicine.
- Overcoming evidentiary, implementation, and governance challenges is crucial for realizing clinical benefits.
Related Concept Videos
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Cardiomyopathy V: Interprofessional Care
Imaging Studies for Cardiovascular System V: CT
Imaging Studies for Cardiovascular System IV: CMRI

